BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22456485)

  • 1. Changing stripes to avoid graft versus leukemia.
    Spitzer TR
    Transplantation; 2012 Apr; 93(7):674-5. PubMed ID: 22456485
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on the clinical effect and in vitro study of HLA-mismatched hematopoietic stem cell infusion for acute myeloid leukemia.
    Zhang R; Zhao F; Wang J
    Hematology; 2015 Dec; 20(10):555-60. PubMed ID: 26067370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of mismatched HLA in myeloid/NK cell precursor acute leukemia relapse after T cell-replete haploidentical hematopoietic stem cell transplantation.
    Kobayashi S; Kikuta A; Ito M; Sano H; Mochizuki K; Akaihata M; Waragai T; Ohara Y; Ogawa C; Ono S; Ohto H; Hosoya M
    Pediatr Blood Cancer; 2014 Oct; 61(10):1880-2. PubMed ID: 24464971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral myeloid sarcoma of the breast and cerebrospinal fluid as a relapse of acute myeloid leukemia after stem-cell transplantation: a case report.
    Toumeh A; Phinney R; Kobalka P; Mohamed I
    J Clin Oncol; 2012 Aug; 30(22):e199-201. PubMed ID: 22734027
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained expression of nucleophosmin (NPM1) mutation at late relapse presenting as isolated myeloid sarcoma in a patient with acute myeloid leukemia.
    Scholl S; Lüftner J; Mügge LO; Schmidt V; Fricke HJ; Höffken K
    Ann Hematol; 2007 Oct; 86(10):763-5. PubMed ID: 17639390
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic trickery--escape of leukemia from immune attack.
    Barrett J; Blazar BR
    N Engl J Med; 2009 Jul; 361(5):524-5. PubMed ID: 19641211
    [No Abstract]   [Full Text] [Related]  

  • 8. Intermediate dose cytarabine in treatment myeloid sarcoma of the bilateral breast after allogeneic stem cell transplantation: A case report and literature review.
    Aznab M; Khazaie M
    J Cancer Res Ther; 2018; 14(3):703-705. PubMed ID: 29893346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation.
    Choschzick M; Bacher U; Ayuk F; Lebeau A
    J Clin Pathol; 2010 Jun; 63(6):558-61. PubMed ID: 20360144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
    Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
    Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in acute myeloid leukemia.
    Arpinati M; Curti A
    Immunotherapy; 2014; 6(1):95-106. PubMed ID: 24341888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
    Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
    N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtransplantation: a new paradigm for the separation of graft versus host disease and graft versus tumor?
    Spitzer TR
    J Clin Oncol; 2012 Nov; 30(33):4051-2. PubMed ID: 23045583
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation for acute myeloid leukemia.
    Takami A
    Int J Hematol; 2018 May; 107(5):513-518. PubMed ID: 29374826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation for 8 patients with leukemia and review of the literature].
    Xie XS; Wan DM; Sun H
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):636-7. PubMed ID: 21122422
    [No Abstract]   [Full Text] [Related]  

  • 16. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
    Canaani J; Savani BN; Labopin M; Michallet M; Craddock C; Socié G; Volin L; Maertens JA; Crawley C; Blaise D; Ljungman PT; Cornelissen J; Russell N; Baron F; Gorin N; Esteve J; Ciceri F; Schmid C; Giebel S; Mohty M; Nagler A
    Am J Hematol; 2017 Aug; 92(8):789-796. PubMed ID: 28439910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complex mutational profile and a distinct clonal evolution during NPM1 myeloid sarcoma.
    Fouillet L; Daguenet E; Guyotat D; Campos-Guyotat L; Grange R; Cornillon J; Jalaber E; Lejeune C; Tavernier E; Flandrin-Gresta P
    Leuk Lymphoma; 2019 Sep; 60(9):2328-2330. PubMed ID: 30707044
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
    Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up.
    Guo M; Hu KX; Liu GX; Yu CL; Qiao JH; Sun QY; Qiao JX; Dong Z; Sun WJ; Sun XD; Zuo HL; Man QH; Liu ZQ; Liu TQ; Zhao HX; Huang YJ; Wei L; Liu B; Wang J; Shen XL; Ai HS
    J Clin Oncol; 2012 Nov; 30(33):4084-90. PubMed ID: 23045576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.